Mechanism of the ATP-dependent membrane transporter

ATP依赖性膜转运蛋白的机制

基本信息

  • 批准号:
    02660091
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1990
  • 资助国家:
    日本
  • 起止时间:
    1990 至 1991
  • 项目状态:
    已结题

项目摘要

The ATP-dependent membrane transport proteins of eukaryotes includes P-glycoprotein and cystic fibrosis transmembrane conductance regulator(CFIR). P-glycoprotein functions as an ATP-dependent efflux pump of anticancer drugs and is involved in multidrug resistance of cancer cells which is a major obstacle of cancer chemotherapy. CFTR is involved in cystic fibrosis, the most common lethal, recessively inherited disease among Caucasians. This family of membrane transport proteins has a high degree of symmetry between its two halves, each composed of six membrane-spanning alpha-helices and a hydrophilic region containing an ATP-binding sites. To investigate the involvement of the two ATP-binding domains in the ATPase activity of P-glycoprotein, fulllength and the 5'-half of human MDR1 cDNA, which encodes P-glycoprotein, were fused with the E. coli lacZ gene and expressed in NIH3T3 cells. Immunoprecipitated full-length P-glycoprrotein-beta-galactosidase showed ATPase activity in the presenc … More e of phospholipids suggesting that stabilization of the transmembrane domains is necessary for ATP hydrolysis. N-terminal half P-glycoprotein-beta-galactosidase also showed ability to hydrolyze ATP but with slightly lower specific activity. Both ATPase activities showed similar characteristics when the effect of several inhibitors was analyzed, indicating that the N-terminal ATP-binding domain contains all residues necessary to hydrolyze ATP without interacting with the C-terminal ATP-binding domain. Then, MDRI cDNA fragment encoding the NH_2- and COOH-cytoplasmic domains of P-glycoprotein(N-half and C-half, respectively)were isolated and fused with E. coli lacZ gene. The fusion genes were expressed in E. coli strain BL21 using the T7 RNA polymerase expression system. The fusion proteins were purified by affinity chromatography against the beta-galactosidase moiety to near homogeneity. Both ATP-binding doipains of P-glycoprotein showed ATPase activity with similar Km values but the Vmax for the activity of C-half was about half that of N-half. This difference in turnover rates suggests different roles in the transport process. Less
真核生物的ATP依赖性膜转运蛋白包括P-糖蛋白和囊性纤维化跨膜传导调节因子(CFIR)。P-糖蛋白作为ATP依赖的抗癌药物外排泵发挥作用,并参与肿瘤细胞的多药耐药,是肿瘤化疗的主要障碍。CFTR与囊性纤维化有关,囊性纤维化是白种人中最常见的致死性复发性遗传性疾病。这个膜转运蛋白家族在其两个半部分之间具有高度对称性,每个半部分由六个跨膜α-螺旋和含有ATP结合位点的亲水区域组成。为了研究P-糖蛋白ATP酶活性与两个ATP结合区的关系,将人MDR 1全长cDNA和5 ′端cDNA分别与E. colilacZ基因在NIH 3 T3细胞中表达。免疫沉淀的全长P-糖蛋白-β-半乳糖苷酶显示ATP酶活性, ...更多信息 表明跨膜结构域的稳定是ATP水解所必需的。N-末端半P-糖蛋白-β-半乳糖苷酶也显示出水解ATP的能力,但比活性略低。两种ATP酶活性显示出相似的特性时,几种抑制剂的影响进行了分析,表明N-末端ATP结合结构域包含所有必要的残基水解ATP,而不与C-末端ATP结合结构域相互作用。然后,分离编码P-糖蛋白NH_2-和COOH-胞浆区(分别为N-半和C-半)的MDRI cDNA片段,并与E.大肠杆菌lacZ基因。融合基因在E. coli菌株BL 21中进行表达。通过针对β-半乳糖苷酶部分的亲和层析将融合蛋白纯化至接近同质。P-糖蛋白的两种ATP结合蛋白酶都具有相似的Km值,但C-半的Vmax约为N-半的一半。周转率的这种差异表明在运输过程中的不同作用。少

项目成果

期刊论文数量(35)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Saeki T.: "Expression of human Pーglycoprotein in yeast cellsーEffect of membrane component sterols on the activity of Pーglycoprotein" Agric.Biol.Chem.55. 1859-1865 (1991)
Saeki T.:“酵母细胞中人 P-糖蛋白的表达 - 膜成分甾醇对 P-糖蛋白活性的影响”Agric.Biol.Chem.55 1859-1865 (1991)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Chen,Cーj.: "Genomic organization of the human multidrug resistance MDRl gene and origin of Pーglycoproteins" J.Biol.Chem.265. 506-514 (1990)
Chen,C-j.:“人类多药抗性MDR1基因的基因组组织和P-糖蛋白的起源”J.Biol.Chem.265(1990)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Shimabuku A. M.: "Production of a site specifically cleavable P-glycoprotein-b-galactosidase fusion protein." Agric. Eiol. Chem.55. 1075-1080 (1991)
Shimabuku A. M.:“产生位点特异性可裂解的 P-糖蛋白-b-半乳糖苷酶融合蛋白。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sugawara I.: "Primerーdependent amplification of mdrl mRNA by polymerase chain reaction." Jpn.J.Cancer Res.83. 131-133 (1992)
Sukawara I.:“通过聚合酶链式反应进行 mdrl mRNA 的引物依赖性扩增。”Jpn.J.Cancer Res.83 (1992)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Chin K-V: "Modulation of activity of the promoter of the human MDRl gene by Ras and p53." Science. 255. 459-462 (1992)
Chin K-V:“Ras 和 p53 对人 MDR1 基因启动子活性的调节”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

UEDA Kazumitsu其他文献

UEDA Kazumitsu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('UEDA Kazumitsu', 18)}}的其他基金

Physiological substrates and functions of ABC proteins involved in lipid transport
参与脂质转运的 ABC 蛋白的生理底物和功能
  • 批准号:
    20228001
  • 财政年份:
    2008
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Molecular mechanism of ATP-dependent transporters involved in cholesterol homeostasis
ATP依赖性转运蛋白参与胆固醇稳态的分子机制
  • 批准号:
    14360053
  • 财政年份:
    2002
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A novel signal transduction mechanism via intracellular ATP sensor
通过细胞内 ATP 传感器的新型信号转导机制
  • 批准号:
    09660086
  • 财政年份:
    1997
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanism of steroid transporter P-glycoprotein
类固醇转运蛋白P-糖蛋白的分子机制
  • 批准号:
    04660085
  • 财政年份:
    1992
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

P-glycoprotein与Rack1和Src相互作用并促进耐药乳腺癌细胞侵袭转移的分子机制研究
  • 批准号:
    81472474
  • 批准年份:
    2014
  • 资助金额:
    85.0 万元
  • 项目类别:
    面上项目

相似海外基金

Inhibition or evasion of P-glycoprotein-mediated drug transport
抑制或逃避 P-糖蛋白介导的药物转运
  • 批准号:
    10568723
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Physiological function of P-glycoprotein in sanctuary tissue barriers in teleosts
P-糖蛋白在硬骨鱼保护区组织屏障中的生理功能
  • 批准号:
    RGPIN-2020-04905
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Discovery Grants Program - Individual
Studies of P-glycoprotein Drug Interactions - Administrative Supplement for Undergraduate Summer Research
P-糖蛋白药物相互作用的研究 - 本科生暑期研究行政补充
  • 批准号:
    10810072
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Bacterial targeting of the P-glycoprotein/endocannabinoid axis for reducing intestinal inflammation in ulcerative colitis
细菌靶向 P-糖蛋白/内源性大麻素轴以减少溃疡性结肠炎的肠道炎症
  • 批准号:
    10537517
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Studies of P-glycoprotein drug interactions
P-糖蛋白药物相互作用的研究
  • 批准号:
    10661486
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Drug, Nucleotide, and Lipid Interactions with P-glycoprotein
药物、核苷酸和脂质与 P-糖蛋白的相互作用
  • 批准号:
    10672242
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Mechanisms of suicide attempts by loss of P-glycoprotein function in the blood-brain barrier
血脑屏障中 P-糖蛋白功能丧失导致自杀未遂的机制
  • 批准号:
    22K06774
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies of P-glycoprotein drug interactions
P-糖蛋白药物相互作用的研究
  • 批准号:
    10366914
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Studies of P-glycoprotein Drug Interactions - Administrative Supplement for Equipment Purchase
P-糖蛋白药物相互作用研究-设备采购行政补充
  • 批准号:
    10795338
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Organic Anion Transporting Polypeptide (OATP), P-glycoprotein (P-gp), and Breast Cancer Resistance Protein (BCRP) transporters modulate tamoxifen response during breast cancer therapy
有机阴离子转运多肽 (OATP)、P-糖蛋白 (P-gp) 和乳腺癌抗性蛋白 (BCRP) 转运蛋白在乳腺癌治疗期间调节他莫昔芬反应
  • 批准号:
    452037
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了